ArticleFrontiers in immunology2026

Polysaccharide microparticles as an oral vaccine platform: proof-of-concept in male rats using a GnRH-targeting fusion antigen.

Maximiliano Wilda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.